Congress Weighs Repeal of Tax Credit for Rare Disease Drugs

Long untouchable, the incentive for development of orphan drugs is now a Republican target as lawmakers consider a broad tax overhaul.

from NYT > Health http://ift.tt/2zH8W7L
via health&fitness